Skip to main content
. 2020 Dec 4;9(12):868. doi: 10.3390/antibiotics9120868

Table 5.

Effects of disulfiram treatment on bartonella co-infection of Lyme disease (n = 12).

Patient ID M/F Age Weight (kg) Max Dose (mg/kg/day) Duration Infection & Other Conditions Other Rx Adverse Reaction Benefit
2 F 24 57 5.5 5 MO Bb, Bh PN, FAT Y
16 M 21 60 8.3 12 WK Bb, Bm, Bh Psych, FAT, LFT Y E
19 F 46 55 6.8 10 WK Bb, Bh azith, rifam FAT Y
21 F 62 75 6.7
6.7
6 WK
3 MO
Bb, Bh FAT Y
Y E
22 M 28 59 6.4 6 WK Bb, Bh, Imm Def N
39 F 59 63 6
2
5 MO
4 MO+
Bb, Bh azith+, rifam FAT, Arth, Psych N
Y
41 M 21 91 0.9 8 WK Bb, Bh unclear
48 F 64 66 0.9
0.9
4 MO
3 MO+
Bb, Bh FAT, LFT Y
Y
53 F 23 95 1.6 7 MO Bb, Bh PN, Arth Y
54 M 73 85 4.4 4 MO+ Bb, Bm, Bh mino, rifam Y
re-bitten
55 M 17 84 1.5 2 MO+ Bb, Bh azith, rifam Y
65 F 43 49 2.5
0.4
4 MO
4 MO+
Bb, Bm, Bh FAT, Psych Y
Y